Cart
sales@molnova.com
Entecavir hydrate
CAS No. 209216-23-9
Entecavir hydrate( Baraclude | BMS 200475 | SQ 34,676 )
Catalog No. M13277 CAS No. 209216-23-9
Entecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 73 | In Stock |
|
| 25MG | 110 | In Stock |
|
| 50MG | 151 | In Stock |
|
| 100MG | 226 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEntecavir hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEntecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
-
DescriptionEntecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus (HBV).
-
In Vitro——
-
In Vivo——
-
SynonymsBaraclude | BMS 200475 | SQ 34,676
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHBV( HepG2 cell)
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number209216-23-9
-
Formula Weight295.3
-
Molecular FormulaC12H15N5O3·H2O
-
Purity>98% (HPLC)
-
SolubilityDMSO: 59 mg/mL (199.8 mM)
-
SMILESC=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N.O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Levine S, et al. Antimicrob Agents ChemOthers, 2002, 46(8), 2525-2532.
molnova catalog
related products
-
Pamidronate disodium...
Pamidronate disodium, a bisphosphonate drug, can help to strengthen bones.
-
AT-130
AT-130 is a potent inhibitor of HBV capsid assembly, inhibits wild-type HBV replication with IC50 of 2.4 uM.
-
Canocapavir
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
